M1 Kliniken AG successfully held its annual general meeting 2021

DGAP-News: M1 Kliniken AG / Keyword (s): AGA / EGM / Miscellaneous
16.07.2021 / 09:24
The issuer is solely responsible for the content of this advertisement.

M1 Kliniken AG successfully held its annual general meeting 2021

Berlin, July 16, 2021 – M1 Kliniken AG (ISIN: DE000A0STSQ8) successfully held its 2021 Annual General Meeting on July 14, 2021.

Following the Corona restrictions of the previous year, the board of directors is confident about the development of the company in the current financial year and in the future.

In its presentation, the Management Board gave an overview of the successful development of the company during the financial year 2020, even if considerable restrictions on commercial activity had to be absorbed due to the official foreclosure orders. Due to the very rapid achievement of high occupancy rates after the reopening of the specialized centers, the board of directors is convinced that the Corona pandemic will not have a negative impact on the continued development of M1 business. in the medium and long term. The first intermediate goal is to operate a total of around 50 specialist centers by the end of 2021.

The Management Board also commented on the context of the 75% stake in Haemato AG at the end of the 2020/21 financial years. In addition to concentrating the business activities of the two companies, the private label activity in the field of aesthetic medicine will be extended.

In total, 77.5% of the share capital was represented at the General Meeting. The agenda included the resolution on the allocation of the balance sheet income for 2020, the discharge of members of the Management Board and the Supervisory Board, and the election of the statutory auditor for the 2021 financial year. The resolution on all the items on the agenda was adopted by a large majority.

The detailed results of the vote have been published at: https://www.m1-kliniken.de/aktie/hauptversammlung.html.

About M1 Kliniken AG

M1 Kliniken AG is the leading provider of health and beauty services in Germany. In the aesthetic and surgical field, the group of companies offers products and services to the highest quality standards. Under the “M1 Med Beauty” brand, medico-aesthetic treatments are currently offered in more than 40 specialized centers. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theaters and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has continued its internationalization and is now also present in Austria, Switzerland, the Netherlands, England, Croatia and Australia. With its participation in HAEMATO AG, which has existed since mid-2020, M1 Kliniken AG is also able to exploit the sales and profit potential of treatment products in the medical-aesthetic field.

M1 Kliniken AG
Dr Walter von Horstig, Board of Directors
Grünauer Street 5
12557 Berlin
T: +49 (0) 30 347 47 44 14
M: [email protected]

07/16.2021 Distribution of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this advertisement.

DGAP’s distribution services include regulatory announcements, financial / corporate news, and press releases.
Archives on www.dgap.de

Source link

Comments are closed.